Other publications in Investigational New Drugs

Randomized phase II trial of neoadjuvant everolimus in patients with high-risk localized prostate ca...

Published in Apr 30, 2019

The metronomic all-oral DEVEC is an effective schedule in elderly patients with diffuse large b-cell...

Published in Apr 26, 2019

Correction to: Eribulin, trastuzumab, and pertuzumab as first-line therapy for patients with HER2-po...

Published in Apr 25, 2019

Correction to: Phase II study of sunitinib in Japanese patients with unresectable or metastatic, wel...

Published in Mar 23, 2019

Eribulin, trastuzumab, and pertuzumab as first-line therapy for patients with HER2-positive metastat...

Published in Mar 08, 2019